Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
REBAMIPIDE THERAPEUTIC AGENT FOR ALLERGIC CONJUNCTIVITIS
Document Type and Number:
WIPO Patent Application WO/2013/108644
Kind Code:
A1
Abstract:
The present invention relates to an allergic conjunctivitis therapeutic agent having rebamipide or a pharmaceutically acceptable salt thereof as an active constituent.

More Like This:
JP2014507452Quinoline derivative
WO/2001/028515PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MUCOSAL EPITHELIAL ULCERATION AND/OR EROSION
JP5791737A dry powder formulation of particles containing two or more active ingredients for the treatment of obstructive or inflammatory airway diseases
Inventors:
KINOSHITA SHIGERU (JP)
UETA MAYUMI (JP)
Application Number:
PCT/JP2013/050042
Publication Date:
July 25, 2013
Filing Date:
January 07, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYOTO PREFECTURAL PUBLIC UNIV CORP (JP)
OTSUKA PHARMA CO LTD (JP)
International Classes:
A61K31/4704; A61P27/14; C07D215/22
Domestic Patent References:
WO2009128934A12009-10-22
WO2010039939A12010-04-08
Foreign References:
JPH09301866A1997-11-25
JP2003201250A2003-07-18
JPS597168A1984-01-14
Attorney, Agent or Firm:
SAMEJIMA, Mutsumi et al. (JP)
Mutsumi Sameshima (JP)
Download PDF:
View/Download PDF      PDF Help
Claims:



 
Previous Patent: COMPRESSED SOFT MAGNETIC POWDER BODY

Next Patent: HYDROGEN SULFIDE GAS PRODUCTION PLANT AND METHOD FOR RECOVERING AND USING WASTE HYDROGEN SULFIDE GAS